Silicosis is an incurable occupational disease associated with inflammation， fibroblast proliferation and the accumulation of extracellular matrix in lung tissues. The dysregulation of lncRNAs and miRNAs has been implicated in many complex diseases; however， the current understanding of their roles in fibrotic lung diseases， especially silicosis， remains limited. Our previous microRNA (miRNA， miR) microarray data have indicated decreased expression levels of miR-489 in lung tissues of silica-induced pulmonary fibrosis. Here， we further explored the role of miR-489 in a mouse model of silicosis. Interestingly， miR-489 levels were reduced in both macrophages that were exposed to silica and fibroblas... More
Silicosis is an incurable occupational disease associated with inflammation， fibroblast proliferation and the accumulation of extracellular matrix in lung tissues. The dysregulation of lncRNAs and miRNAs has been implicated in many complex diseases; however， the current understanding of their roles in fibrotic lung diseases， especially silicosis， remains limited. Our previous microRNA (miRNA， miR) microarray data have indicated decreased expression levels of miR-489 in lung tissues of silica-induced pulmonary fibrosis. Here， we further explored the role of miR-489 in a mouse model of silicosis. Interestingly， miR-489 levels were reduced in both macrophages that were exposed to silica and fibroblasts that were exposed to TGF-β1. Additionally， the overexpressed miR-489 carried out its anti-fibrotic role by attenuating inflammation and fibrotic progression in vivo. Our molecular study further demonstrated that miR-489 inhibited silica-induced pulmonary fibrosis primarily by repressing its target genes MyD88 and Smad3. Moreover， the up-regulated lncRNA cardiac hypertrophy-related factor (CHRF) reversed the inhibitory effect of miR-489 on MyD88 and Smad3 and then triggered the inflammation and fibrotic signaling pathways. Overall， our data indicate that the CHRF-miR-489-MyD88 Smad3 signaling axis exerts key functions in silica-induced pulmonary fibrosis and may represent a therapeutic target for silicosis.
